Comments of Members of the Patient, Consumer, and Public Health Coalition on “Testicular Toxicity: Evaluation During Drug Development – Guidance for Industry” [Docket No. FDA-2015-D-2306-0001] We appreciate the opportunity to provide feedback to the FDA on the evaluation of testicular toxicity during drug development. The recommendations in the draft guidance are very important and we […]
Federal employees can learn more about the Cancer Prevention and Treatment Fund (CFC #11967) when we’re at CFC events.
The bill’s laundry list of provisions that tweak the process for approving new drugs or devices have raised significant concern from industry watchdogs and physicians who say the legislation is aimed more at helping drug and device companies than patients.
Dr. Diana Zuckerman, PhD July 20, 2015 We are greatly disappointed by the passage of the 21st Century Cures Act by the House of Representatives. We share Congress’ desire to increase funding for NIH, but there are dangerous provisions in this bill that undermine scientific evidence used to approve medical products. However, this was a very […]
Washington Post, June 17, 2015. A new study published Tuesday in the Journal of Clinical Endocrinology and Metabolism found a startling link between pregnant women exposed to DDT and the breast cancer risk to their daughters.
We Need Better Clinical Trials Our president explained to reporters why drugs have to be tested on all kinds of people to know who they work for and who can be harmed by them. Cancer patients deserve studies that include women and men, people under and over 65, and all major racial/ethnic groups. FDA […]